Literature DB >> 35923330

Incidental littoral cell angioma of the spleen: cross-sectional imaging findings and review of the literature.

Pier Paolo Arcuri1, Stefano Taglianetti2, Barbara Vavalà1, Caterina Battaglia2, Domenico Laganà2, Francesco Manti2.   

Abstract

Littoral cell angioma (LCA) is a primary splenic hemangioma found mostly in normal red sinus shore cells of the reticuloendothelial cell system of the spleen. In most cases is benign, but sometimes malignancies have been reported. This tumor displayed epithelial and histiocytic properties based on its cell of origin, splenic littoral cells. In this case report, we will describe a case of a 21-year-male presenting with an incidentally discovered LCA illustrated by cross-sectional imaging techniques, highlighting how the diffusional sequence and the positron emission tomography study, thanks to their greater specificity, have contributed to reaching a correct diagnostic orientation more than dynamic studies with contrast agent in both computed tomography and magnetic resonance.
© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Diffusion-MRI; FDG-PET/CT; Littoral cell angioma; Spleen

Year:  2022        PMID: 35923330      PMCID: PMC9340147          DOI: 10.1016/j.radcr.2022.06.063

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Primary splenic tumors are uncommon and classified as lymphoid, non-lymphoid, and tumor-like lesions [1]. Primary vessel tumors are the most common type of non-lymphomatous tumor of the spleen, most of which are benign, mainly arising from the blood vessels, especially veins, and less commonly originating from red-pulp sinuses lined by littoral cells. Littoral cell angioma (LCA), first described in 1991 [2], is a rare vascular tumor of the spleen which displays both epithelial and histiocytic properties based on their cell of origin, the splenic littoral cells lining the sinuses of the splenic red pulp. Initially thought to be benign, the biologic behavior of LCA has not been firmly established, as there have been several reports of LCA with malignant features [3], [4], [5]. LCA may occur at any age and has no gender predilection; this lesion may be accidentally found in patients with abdominal pain [6]. Moreover, LCA could be discovered as a splenic lesion in patients whit laboratory evidence of hypersplenism, including anemia or thrombocytopenia, and constitutional symptoms including fever [2,[7], [8], [9], [10]]. One hundred forty-seven cases have been reported in the international literature, but only one showed ultrasound, contrast-CT, contrast-MRI, and PET-CT imaging findings [11]. However, imaging findings of LCA (US, MRI, and CT) are nonspecific, and splenomegaly is a common finding. Due to the nonspecific imaging findings in the diagnostic work-up, splenectomy is often performed for diagnostic and therapeutic purposes [12]. Currently, both etiology as well as biological behavior, remains uncertain. Due to increasing numbers of LCA in association with autoimmune disorders such as Crohn's disease and inborn metabolic diseases such as Gaucher's disease, as with visceral organ tumors, immune system dysfunction has been postulated as a possible crucial pathogenic mechanism [2,[13], [14], [15], [16]].

Case presentation

A 21-year-male was admitted to our hospital for abdominal trauma. The patient was asymptomatic without abdominal pain, fever, chills, weight loss, or other constitutional symptoms. No comorbidity was found in his past medical history. Both physical examination and biochemical tests were negative to pathological findings; he was not leukopenic, anemic, or thrombocytopenic. Ultrasound (Fig. 1) demonstrated no traumatic lesions of the liver, kidneys, and spleen. Still, it showed multiple solid hypoechoic nodules with regular margins, high vascularization (founded with the color Doppler examination), and without back wall reflections in the splenic parenchyma. Of note, the spleen presented average size.
Fig. 1

Ultrasound shows the presence of multiple, solid-looking, focal hypoechoic lesions with regular margins.

Ultrasound shows the presence of multiple, solid-looking, focal hypoechoic lesions with regular margins. After we have excluded post-traumatic lesions from being urgently managed, pre- and postcontrast CT examination was planned to define the nature of the lesions. An enhanced CT demonstrated multiple rounds, low hypoattenuating lesions in the spleen (Fig. 2a), significant contrast enhancement in the arterial phase, and slightly less noticeable in the venous stages (Figs. 2b and 2c). No significant abdominal adenopathy suggesting a possible lymphomatous etiology was found.
Fig. 2

(A) Baseline CT confirms the presence of multiple focal splenic lesions, homogeneously hypodense with clear margins. Absence of loco-regional lymph adenomegaly. The spleen is of regular size. (B) CT (arterial phase) shows intense enhancement of the previously reported focal splenic lesions. (C) CT (portal phase) shows moderate persistence of the contrast medium in the lesions.

(A) Baseline CT confirms the presence of multiple focal splenic lesions, homogeneously hypodense with clear margins. Absence of loco-regional lymph adenomegaly. The spleen is of regular size. (B) CT (arterial phase) shows intense enhancement of the previously reported focal splenic lesions. (C) CT (portal phase) shows moderate persistence of the contrast medium in the lesions. Furthermore, a pre- and postcontrast agent MRI study was performed to highlight the possible presence of any small "islands" of adipose tissue in the context of the lesions. The lesions were homogeneously hypointense on T1-weighted in-phase and out-of-phase (IP/OP) gradient-echo imaging sequences (Figs.3a and b) and slightly hyperintense on T2-weighted images (TSE: Fig. 3c, STIR: Fig. 3d). The diffusion sequence (DWI) and the corresponding ADC map (Figs. 3e and f) showed a Diffusion coefficient equal to 1.43 × 10−3 mm2 / sec, compatible with benign lesions (cut-off: 1.21 × 10−3) [17].
Fig. 3

(A) MRI (SE T1 in-phase) shows homogeneous hypo-intensity of splenic lesions. (B) MRI (SE T1 out-phase) shows homogeneous hypo-intensity of splenic lesions. (C) MRI (TSE T2 W) shows homogeneous hyperintensity of splenic lesions. (D) MRI (STIR sequence) shows homogeneous hyperintensity of splenic lesions. (E) MRI (DWI sequence, b value = 600) shows homogeneous hyperintensity of splenic lesions, compatible with the absence of significant lesion restriction phenomena. (F) MRI (ADC Map). The ADC map shows a value = 1.43 × 10−3 confirming the absence of restriction.

(A) MRI (SE T1 in-phase) shows homogeneous hypo-intensity of splenic lesions. (B) MRI (SE T1 out-phase) shows homogeneous hypo-intensity of splenic lesions. (C) MRI (TSE T2 W) shows homogeneous hyperintensity of splenic lesions. (D) MRI (STIR sequence) shows homogeneous hyperintensity of splenic lesions. (E) MRI (DWI sequence, b value = 600) shows homogeneous hyperintensity of splenic lesions, compatible with the absence of significant lesion restriction phenomena. (F) MRI (ADC Map). The ADC map shows a value = 1.43 × 10−3 confirming the absence of restriction. However, dynamic postcontrast MRI imaging (Gadoxetic acid) showed rapid wash-in with a peek at 2 minutes, followed by a significant wash-out at the 4th minute (Fig. 4); this behavior was suspicious for lesions with significant contextual neoangiogenesis. Therefore, our presumptive preoperative diagnosis was atypical hemangiomas, hamartomas, or diffuse low-grade hemangiosarcoma. In addition, a positron emission tomographic (PET) scan was performed and showed no increased fluorodeoxyglucose localization corresponding to the splenic abnormalities noted on the prior CT examination, suggesting a benign process (Fig. 5). Given the uncertain nature of this incidentally discovered splenic lesion, we proposed an operative resection with laparoscopic splenectomy for diagnostic and therapeutic purposes. The 12 × 8 × 4 cm specimen (Fig. 2) showed multiple nodular lesions with a spongy appearance, varying from 0.5 to 3.5 cm. Microscopically, these lesions were described as a vascular neoplasm forming anastomosing vascular channels lined by histiocytes with occasional papillary structure (Fig. 6). The lacunae were filled with edematous fluid and blood. Immunohistochemical staining was positive for endothelial (CD 31) and histiocytic (CD 68) markers. No cytologic atypia and mitotic figures were found. The combination of morphological and immunohistochemical analysis presenting this hybrid endothelial-histiocytic phenotype established the diagnosis of LCA. The operation and recovery were uneventful, and the patient was discharged on postoperative day 4. He will be followed up closely for the occurrence of visceral neoplasms.
Fig. 4

The dynamic study with MRI shows intense enhancement after contrast agent with significant wash-out in the subsequent phases.

Fig. 5

The CT-18 FDG-PET examination shows the absence of FDG uptake in spleen lesions.

Fig. 6

Photomicrograph of the littoral cell angioma (hematoxylin-eosin, original magnification 50 ×). Microscopically, the lesion shows vascular neoplasms forming anastomosing vascular channels lined by histiocytes with occasional papillary structure, consistent with littoral cell angioma. These cells expressed vascular markers by immunohistochemistry (FVIII, CD31, and CD34).

The dynamic study with MRI shows intense enhancement after contrast agent with significant wash-out in the subsequent phases. The CT-18 FDG-PET examination shows the absence of FDG uptake in spleen lesions. Photomicrograph of the littoral cell angioma (hematoxylin-eosin, original magnification 50 ×). Microscopically, the lesion shows vascular neoplasms forming anastomosing vascular channels lined by histiocytes with occasional papillary structure, consistent with littoral cell angioma. These cells expressed vascular markers by immunohistochemistry (FVIII, CD31, and CD34).

Discussion

LCA is a rare vascular neoplasm that occurs exclusively in splenic tissue and was first described by Falk et al in 1991 [2]. It originates from the specialized endothelial cells lining the sinus channels of the splenic red pulp, called “littoral cells”. LCA affects both men and women equally. Due to nonspecific clinical symptoms, LCA is most often found incidentally as a splenic mass on abdominal imaging. Two instances of LCA presenting splenic rupture and hemoperitoneum have been reported [18,19]. Moreover, about 50% of patients give splenomegaly or signs of hypersplenism like anemia or thrombocytopenia [2,7]. LCA is often multifocal, and lesions can vary in size [4]. Radiological diagnostic imaging can hardly achieve a definitive diagnosis of LCA because of its similar appearance to both benign splenic neoplasms (hemangiomatosis, lymphangiomatosis, hamartoma, hemangiopericytoma and hemangioendothelioma) and malignant tumors (angiosarcoma, lymphoma, Kaposi sarcoma, and metastasis). Multiple imaging modalities have been used to evaluate LCA. However, there does not seem to be a superior option, and findings are inconsistent because of the vascular nature and variability of the tumor [11]. Sonography is rarely helpful because the findings vary widely. The sonographic features of LCA are variable and range from heterogeneous echotexture without specific nodules [20] to hyperechogenic [21], hypoechogenic [9], or echogenic [22] appearing lesions [8,10,23]. LCA masses are only rarely visible; however, early-phase contrast-enhanced CT may appear as multiple low-attenuation lesions related to the surrounding splenic parenchyma. On delayed images, they are generally isodense with the surrounding enhancing splenic tissue [11,[24], [25], [26]]. In contrast with most literature, our CT scan showed significant enhancement in the arterial phase, disorienting us toward a correct diagnostic hypothesis. Magnetic resonance imaging of the spleen may further help in the diagnosis by showing hypointense lesions on both T1-weighted and T2-weighted scans [27]. In our case, MRI imaging demonstrated the hypointense lesions on T1 weighted and hyperintense on T2-weighted images. Maybe due to an inferior hemosiderin content of LCA. Moreover, DWI sequence, ADC map, and dynamic contrast graphic images may be helpful as diagnostic tools in the differential diagnosis among malignant and benign splenic processes; in our case, DWI images and relative fiffusion coefficient showed the average value typical for benign lesions, while the dynamic postcontrast images showed, after an early arterial wash-in, an average early wash-out (already significant at the 4th minute), therefore, suspicious for malignant neoplasia (intensely vascularized). Hence, the need to perform a further diagnostic test, a PET scan. PET scan showed no increased fluorodeoxyglucose localization corresponding to the splenic abnormalities noted on the prior CT examination in the only case reported in the literature [11]. Percutaneous biopsy of splenic lesions, with both CT and US guidance, has been successfully performed in many instances of LCA [28,29]. Still, this approach is controversial because of the risk of hemorrhage pneumothorax and other complications [30]. Radiological findings are rarely sufficient for making a definitive diagnosis because many other splenic neoplasms can mimic LCA. Several differential diagnoses must be considered. These include benign neoplasms like hamartoma, hemangioma, or lymphangiomatosis, as well as malignant tumors such as lymphoma or angiosarcoma, but also metastatic diseases or disseminated infections such as fungal disease, septic emboli, and granulomatous diseases [20]. Mycobacterium avium-intracellular complex, Pneumocystis carinii, and disseminated Kaposi sarcoma may also cause splenic masses but are typically seen in immunocompromised individuals. Since our patient did not present any adenopathy or diseases in other organs, metastatic disease was considered an unlikely diagnosis. However, a definite diagnosis is often difficult to obtain, and splenectomy is subsequently performed for diagnostic and therapeutic purposes. Pathologically, LCA typically shows multiple focal blood-filled nodules, and microscopic examination reveals anastomosing vascular channels lined with tall endothelial cells and papillary projections [2,8,12]. Since the littoral cells have features intermediate between endothelial cells and macrophages, they show a hybrid endothelial-histiocytic phenotype on immunohistochemical staining. Immunohistochemically, LCA is characteristically CD 34 negative, CD 68 positive, CD 31 positive, 21 positive, and 8 negatives [31]. Additionally, the epithelial cells in LCA do occasionally express S-100 protein [32]. High expression of forming homology domain protein 1 (FHOD1), a typical feature of normal littoral cells, not of LCA, distinguished these [33]. Further research has been done evaluating molecular markers and LCA to help aid in the accurate diagnosis of LCA tumors. LCA has most commonly been described as a benign lesion even if there are some reports of LCA with malignant features: a low-grade variant (littoral cell hemangioendothelioma) [4] and the tumor's malignant counterpart, littoral cell angiosarcoma [34]. Furthermore, in one case, metastatic lesions were found in the liver and retroperitoneum 4 years after splenectomy for LCA [35]. The etiology of this neoplasm remains unclear. A few reports in the international literature have described association with visceral organ tumors, including colorectal adenocarcinoma, hepatocellular carcinoma, non–small cell lung cancer, renal cell cancer, pancreatic cystadenocarcinoma, pancreatic neuroendocrine tumor, seminoma, ovarian cystadenocarcinoma, papillary thyroid cancer, and transitional cell carcinoma of the bladder [1,7]. Other reports have shown an association between LCA and immunological disorders, such as ankylosing spondylitis, myelodysplastic syndrome, aplastic anemia, non-Hodgkin lymphoma, Crohn's disease, and Gaucher's disease [7,34,36] so that an etiological association with immune dysregulation has been proposed [2,[13], [14], [15], [16]]. Due to possible malignant features of LCA and the described association with other malignancies, patients with suspected LCA should undergo close follow-up after splenectomy. LCA is typically an incidental finding on diagnostic imaging workup, as in our case, without specific imaging features. Even if DWI sequences and PET scans may be other useful diagnostic tools in differentiating benign from malignant spleen lesions, a specific radiological diagnosis of LCA seems impossible. So, a particular diagnosis requires histologic examination [12].

Conclusions

This rare case presented, atypical for some imaging aspects, highlighting the imaging features in the different methods, allowed us to define the decisive role of DWI sequence and PET study in orienting the diagnosis toward benign lesions. Moreover, gold standard management remains splenectomy, and long-term follow-up for the development of synchronous tumors or metastatic lesions is advised.
  35 in total

Review 1.  Littoral cell angioma of the spleen in a patient with Gaucher disease.

Authors:  M K Gupta; M Levin; N S Aguilera; G M Pastores
Journal:  Am J Hematol       Date:  2001-09       Impact factor: 10.047

2.  Littoral cell angioma of the spleen in a patient with severe aplastic anaemia.

Authors:  Eleni Tholouli; Jo-An Roulson; Richard Byers; Ian Burton; John A Liu Yin
Journal:  Haematologica       Date:  2003-11       Impact factor: 9.941

3.  Littoral cell angioma.

Authors:  Craig Johnson; Manish Goyal; Ben Kim; Dan Wasdahl; Ken Nazinitsky
Journal:  Clin Imaging       Date:  2007 Jan-Feb       Impact factor: 1.605

4.  Littoral cell angioma of the spleen: US and MR imaging findings.

Authors:  J M Oliver-Goldaracena; A Blanco; M Miralles; M A Martin-Gonzalez
Journal:  Abdom Imaging       Date:  1998 Nov-Dec

5.  Littoral cell angioma: A case report.

Authors:  Amanda Bailey; Jeffrey Vos; Jon Cardinal
Journal:  World J Clin Cases       Date:  2015-10-16       Impact factor: 1.337

Review 6.  Splenic littoral cell haemangioendothelioma: a new low-grade variant of malignant littoral cell tumour.

Authors:  O Ben-Izhak; J Bejar; S Ben-Eliezer; E Vlodavsky
Journal:  Histopathology       Date:  2001-11       Impact factor: 5.087

Review 7.  Image-guided percutaneous splenic interventions.

Authors:  Ajay K Singh; Sridhar Shankar; Debra A Gervais; Peter F Hahn; Peter R Mueller
Journal:  Radiographics       Date:  2012 Mar-Apr       Impact factor: 5.333

Review 8.  From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation.

Authors:  Robert M Abbott; Angela D Levy; Nadine S Aguilera; Luis Gorospe; William M Thompson
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

Review 9.  Littoral cell angioma of the spleen: report of three cases and literature review.

Authors:  Jun Du; Qin Shen; Honglin Yin; Xiaojun Zhou; Bo Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 10.  Splenic vascular tumors.

Authors:  Jeffery L Kutok; Christopher D M Fletcher
Journal:  Semin Diagn Pathol       Date:  2003-05       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.